Comments
Loading...
Ocugen (NASDAQ:OCGN) Stock Quotes, Forecast and News Summary
Ocugen Stock (NASDAQ: OCGN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ocugen (OCGN) stock?
You can purchase shares of Ocugen (NASDAQ:OCGN) through any online brokerage.
Who are Ocugen (OCGN) competitors?
Other companies in Ocugen’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Ocugen (OCGN) stock?
Ocugen has a consensus price target of $5.00.
What is the current price for Ocugen (OCGN)?
The stock price for Ocugen (NASDAQ: OCGN) is $0.7623 last updated January 22, 2025 at 1:53 PM EST.
Does Ocugen (OCGN) pay a dividend?
There are no upcoming dividends for Ocugen.
When is Ocugen (NASDAQ:OCGN) reporting earnings?
Ocugen’s Q4 earnings are confirmed for Tuesday, April 1, 2025.
Is Ocugen (OCGN) going to split?
There is no upcoming split for Ocugen.
What sector and industry does Ocugen (OCGN) operate in?
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.